After earning her Ph.D. from the University of Utah in the United States, Dr. Yang returned to Taiwan and joined China Steel Corporation, then became the company’s senior executive in New Materials Development. During her tenure, she focused on the development of new technologies, leading the company towards diversified operations. Driven by her extensive experience in medical biotechnology, Dr. Yang demonstrated exceptional cross-disciplinary investment and management skills. She has held key roles such as General Manager at TaiAn Technologies Corporation, supervisor at ADIMMUNE Corporation, and director at over five additional biomedical companies, successfully fostering the growth of numerous biotech and medtech firms.
Dr.Yang obtained her bachelor’s degree in Chemistry from National Taiwan University and holds a Ph.D. in Chemistry from the University of Utah.